Skip to content
10-Q

Quarterly Report

Diplomat Pharmacy, Inc.

0001104659-19-028608

← back to feed
Filed
May 10, 2019 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2019 · May 3, 2019 74.71M sh
Shares Diluted Q1 2019 · Mar 31, 2019 74.46M sh
Shares Diluted Q1 2019 · Mar 31, 2018 74M sh
Capex Q1 2019 · Mar 31, 2019 $6.84M
Capex Q1 2019 · Mar 31, 2018 $567K
Operating Cash Flow Q1 2019 · Mar 31, 2019 $23.65M
Operating Cash Flow Q1 2019 · Mar 31, 2018 $48.57M
Long Term Debt Q1 2019 · Mar 31, 2019 $436.19M
Long Term Debt Q1 2019 · Dec 31, 2018 $438.37M
Short Term Debt Q1 2019 · Mar 31, 2019 $11.5M
Short Term Debt Q1 2019 · Dec 31, 2018 $11.5M
Cash And Equivalents Q1 2019 · Mar 31, 2019 $2.74M
Cash And Equivalents Q1 2019 · Dec 31, 2018 $9.49M
Cash And Equivalents Q1 2019 · Mar 31, 2018 $6.04M
Cash And Equivalents restated Q1 2019 · Dec 31, 2016 $84.25M
Stockholders Equity Q1 2019 · Mar 31, 2019 $457.88M
Stockholders Equity Q1 2019 · Dec 31, 2018 $465.08M
Stockholders Equity Q1 2019 · Mar 31, 2018 $754M
Stockholders Equity Q1 2019 · Dec 31, 2017 $749.5M
Current Liabilities Q1 2019 · Mar 31, 2019 $517.52M
Current Liabilities Q1 2019 · Dec 31, 2018 $558.59M
Total Liabilities Q1 2019 · Mar 31, 2019 $989.19M
Total Liabilities Q1 2019 · Dec 31, 2018 $1.01B
Current Assets Q1 2019 · Mar 31, 2019 $517.67M
Current Assets Q1 2019 · Dec 31, 2018 $556.26M
Total Assets Q1 2019 · Mar 31, 2019 $1.45B
Total Assets Q1 2019 · Dec 31, 2018 $1.48B
Eps Diluted Q1 2019 · Mar 31, 2019 −$0.19
Eps Diluted Q1 2019 · Mar 31, 2018 −$0.01
Eps Basic Q1 2019 · Mar 31, 2019 −$0.19
Eps Basic Q1 2019 · Mar 31, 2018 −$0.01
Sga Expense Q1 2019 · Mar 31, 2019 $82.87M
Sga Expense restated Q1 2019 · Mar 31, 2018 $81.69M
Net Income Q1 2019 · Mar 31, 2019 −$14.3M
Net Income Q1 2019 · Mar 31, 2018 −$450K
Operating Income Q1 2019 · Mar 31, 2019 −$3.65M
Operating Income Q1 2019 · Mar 31, 2018 $8.69M
Gross Profit Q1 2019 · Mar 31, 2019 $79.22M
Gross Profit restated Q1 2019 · Mar 31, 2018 $90.38M
Cost Of Revenue Q1 2019 · Mar 31, 2019 $1.18B
Cost Of Revenue restated Q1 2019 · Mar 31, 2018 $1.25B
Revenue Q1 2019 · Mar 31, 2019 $1.26B
Revenue Q1 2019 · Mar 31, 2018 $1.34B